OS Therapies Incorporated (OSTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $31.86M
Last updated: Nov 17, 2026 at 4:21 PM ET
OS Therapies Incorporated (OSTX) Statistics
OS Therapies (OSTX) has a market cap of $31.86M and an enterprise value of $33.38M. Its share count is up 48.52% from a year earlier.
Total Valuation
Enterprise value is 4.77% above the market cap, as debt exceeds cash.
| Market Cap | $31.86M |
|---|---|
| Enterprise Value | $33.38M |
| Latest price (Nov 17, 2026) | $0.74 |
Key Dates
| Last Earnings Date | Aug 14, 2026 |
|---|---|
| Fiscal Year End | December |
Price Statistics
The stock is down 58.67% over 52 weeks and trades 46.76% below its 50-day average.
| Beta (1Y) | 1.65 |
|---|---|
| 52-Week Change | -58.67% |
| 1-Month Change | -41.42% |
| 3-Month Change | -49.04% |
| 6-Month Change | -57.73% |
| Total Return (1Y) | -58.67% |
| Max Drawdown (1Y) | -69.61% |
| Max Drawdown (3Y) | -86.81% |
| Sharpe Ratio (1Y) | -1.09 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $1.39 |
| 200-Day Average | $1.53 |
| 52-Week Range | $0.58 to $2.25 |
| RSI (14 Days) | 22.6 |
| Average Volume (20 Days) | 698.13K |
Financial Position
Current assets cover 0.08x current liabilities.
| Current Ratio | 0.08x |
|---|---|
| Quick Ratio | 0.08x |
Returns and Efficiency
Return on invested capital is 218.01% over the last 12 months.
| Return on Assets (ROA) | -539.85% |
|---|---|
| Return on Invested Capital (ROIC) | 218.01% |
Scores
OSTX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$124.94K |
| Operating Income | -$39.77M |
| Pretax Income | -$43.77M |
| Net Income | -$43.77M |
| EBITDA | -$39.41M |
| EBIT | -$41.44M |
| Reported EPS (TTM) | -$1.09 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $431.82K |
|---|---|
| Total Debt | $1.95M |
| Net Debt | $1.52M |
| Net Debt Per Share | $0.03 |
| Working Capital | -$21.93M |
| Shareholder Equity | -$16.97M |
| Tangible Book Value | -$23.10M |
| Total Assets | $8.11M |
| Total Liabilities | $24.01M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$18.48M |
|---|---|
| FCF Per Share | -$0.40 |
| Depreciation and Amortization | $2.04M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
OSTX does not pay a dividend.
| Buyback Yield | -19.22% |
|---|---|
| Shareholder Yield | -19.22% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About OSTX
What is OSTX's market cap?
OS Therapies has a market cap of $31.86M. Its enterprise value, which adds debt and subtracts cash, is $33.38M.
How many shares of OSTX are outstanding?
OS Therapies has 52.30M shares outstanding. The count is up 48.52% from a year earlier.
Does OSTX pay a dividend?
No. OS Therapies does not pay a dividend.
How much debt does OSTX have?
OS Therapies has $1.95M of total debt and $431.82K of cash and equivalents, a net debt position of $1.52M.
OSTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors